Moderna said it will cut production of mRNA drug substance for its COVID-19 vaccine at Lonza’s facility in Switzerland this quarter. The move is part of a plan to align manufacturing of the shots with lower post-pandemic demand. (Reuters)
Mark Zuckerberg and Priscilla Chan’s foundation is funding the construction of a massive computing system for medical research. A press release claims the computing system “will lead to groundbreaking new discoveries that could help cure, prevent, or manage all diseases by the end of this century.” (The Verge)
BioLoomics announced an $8.7 million seed raise led by Innovation Endeavors, the Silicon Valley VC started by former Google CEO Eric Schmidt. Famed Harvard University geneticist George Church also serves as a scientific advisor to the Boulder, Colorado-based company. (Endpoints News)
Samsung Biologics said it had a stellar performance last year and stands shoulder-to-shoulder with top global pharmaceutical companies, buoyed by an array of large contract manufacturing deals. According to Hana Securities, sales of the South Korean biopharma are anticipated to surpass 3.7 trillion won ($2.7 billion) this year. (The Korea Herald)
Republican presidential candidate and former Roivant Sciences CEO Vivek Ramaswamy said he regrets receiving two doses of the COVID-19 vaccine. He also said at a recent campaign stop that he and his wife, surgeon Apoorva Ramaswamy, “disagree on things sometimes.” (NBC News)
